Form 4: FibroGen CFO Sells Shares to Cover Tax Obligations

FibroGen's Chief Financial Officer, Juan Graham, sold a total of 2,512 shares of common stock to cover tax obligations related to vesting restricted stock units.

Summary

• FibroGen's Chief Financial Officer, Juan Graham, sold 1,446 shares of common stock on December 6, 2024, and an additional 1,066 shares on December 7, 2024.
• The sales were executed at a price of $0.3421 per share.
• These transactions were made to satisfy tax obligations arising from the vesting of restricted stock units.
• Following these transactions, Mr. Graham beneficially owns 164,863 shares of FibroGen common stock.

Sentiment

Score: 5

Explanation: The document reflects a routine transaction for tax purposes, not indicative of any positive or negative sentiment towards the company's performance.

Industry Context

This is a routine transaction for executives who receive stock-based compensation. It is common for executives to sell shares to cover tax liabilities when restricted stock units vest.

Comparison to Industry Standards

• Executive stock sales to cover tax obligations are a common practice across the industry.
• Many companies use restricted stock units as part of their compensation packages, leading to similar tax-related sales by executives.
• The volume of shares sold is relatively small compared to the total shares held by the CFO, which is typical for these types of transactions.

Stakeholder Impact

• The stock sales are unlikely to have a significant impact on shareholders as they are routine transactions for tax purposes.

Key Dates

Keywords

FibroGen, FGEN, Juan Graham, CFO, stock sale, tax obligations, restricted stock units, insider trading